Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cosmo to Participate in Upcoming Investor Conferences Ready to Announce with Confidence?

newsfilecorp.com
COSM The article announces Cosmo Pharmaceuticals N.V.'s participation in upcoming investor conferences. While this indicates engagement, it does not provide specific financial or operational updates that would strongly influence sentiment. The company is based in Ireland, but has an office in San Diego, USA, and its stock is traded on NASDAQ.

Dublin, Ireland--(Newsfile Corp. - February 18, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce its participation in the following upcoming investor conferences:

UBS European Healthcare Conference 2026

London, United Kingdom

4 March 2026

Svetlana Sigalova, Chief Financial Officer, will participate in one-on-one meetings with investors.

Jefferies Biotech Summit 2026

Miami, United States

11 March 2026

Giovanni Di Napoli, Chief Executive Officer, will participate in one-on-one meetings with investors.

TP ICAP Healthcare Conference

Paris, France

7 May 2026

Members of the management team will participate in meetings with investors.

Investors attending any of the above conferences who would like to meet with Cosmo are welcome to contact the Company’s IR team to arrange an appointment via investor.relations@cosmohc.com.

About Cosmo

Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.

For further information, please contact:

investor.relations@cosmohc.com

Attachments

PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284298

Source: Cosmo Pharmaceuticals N.V.

Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Cosmo Pharmaceuticals N.V. or all companies in the Health, Healthcare and Hospitals industry.

Cosmo to Participate in Upcoming Investor Conferences

2026-02-18 1:01 AM EST

Cosmo Pharmaceuticals Announces Private Placement of Treasury Shares

2026-02-03 1:10 AM EST

Invitation to Cosmo's Full Year 2025 Financial Results Webcast on 9 March 2026

2026-01-28 1:24 AM EST

Apr 30, 2025

Many public companies struggle to maintain investor visibility and engagement between earnings announcements or major financial events....

Health

Healthcare and Hospitals